Longevity Health Holdings, Inc 8-K, filed Oct 11, 2022
Longevity Health Holdings, Inc. (XAGE)
About this 8-K
Longevity Health Holdings, Inc filed this 8-K on October 11, 2022.
Items reported
- Item 4.01: Change of auditor
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM
CURRENT REPORT
Pursuant to Section 13 or Section 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported):
(Exact name of registrant as specified in its charter)
| (State or other jurisdiction of incorporation or organization) |
(Commission File Number) |
(I.R.S. Employer Identification Number) |
| |
||
| (Address of principal executive offices) | (Zip Code) |
Registrant’s telephone number, including area code
N/A
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation to the registrant under any of the following provisions:
| Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class |
Trading |
Name of each exchange on which registered | ||
| Item 4.01. | Changes in Registrant’s Certifying Accountant. |
(a) Dismissal of Independent Registered Public Accounting Firm
Since January 2021, Marcum LLP (“Marcum”), has been the independent accounting firm of Alpha Healthcare Acquisition Corp. III (the “Company”). On October 4, 2022, the Board of Directors of the Company approved the dismissal of Marcum as the Company’s independent registered public accounting firm.
During the fiscal years ended December 31, 2021, and any subsequent interim period through the date of this report, there were no disagreements within the meaning of Item 304(a)(1)(iv) of Regulation S-K between the Company and Marcum on any matter of accounting principles or practices, financial statement disclosure, or auditing scope or procedure and there are no “reportable events” (as defined in Item 304(a)(1)(v) of Regulation S-K and the related instructions).
The Company has provided Marcum with a copy of the disclosures in this report prior to filing with the Securities and Exchange Commission (the “SEC”).
(b) Engagement of Independent Registered Public Accounting Firm
On October 4, 2022, the Company engaged Adeptus Partners, LLC (“Adeptus”) as the Company’s independent accountant to audit the Company’s consolidated financial statements and to perform reviews of interim financial statements.
During the fiscal year ended December 31, 2021, and then through October 4, 2022, neither the Company nor a anyone acting on its behalf consulted with Adeptus regarding (i) either the application of any accounting principles to a specific completed or contemplated transaction of the Company, or the type of audit opinion that might be rendered by Adeptus on the Company’s consolidated financial statements; or (ii) any matter that was either subject of a disagreement with Marcum or a reportable event with respect to Marcum.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Dated: October 11, 2022
| ALPHA HEALTHCARE ACQUISITION CORP. III | ||
| By: | /s/ Patrick A. Sturgeon | |
| Name: | Patrick A. Sturgeon | |
| Title: | Chief Financial Officer | |